Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02008474 · ClinicalTrials.gov registry record · Phase 3
SHARE Study 4: Financial Incentives for Weight Loss
A Phase 3 study, sponsored by The Miriam Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
NCT02008474: Completed Phase 3 study, sponsored by The Miriam Hospital.
NCT02008474 is a Phase 3 study that has completed, run by The Miriam Hospital. The registered enrollment target is 120 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02008474, a Phase 3 study, has completed, sponsored by The Miriam Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
Study Summary
The purpose of this study is to examine different types of monetary incentive paradigms for weight loss.
Interventions
- BEHAVIORAL Online weight loss + incentives for behavior 3 months
- BEHAVIORAL Online weight loss + incentives for weight loss at month 3
- BEHAVIORAL Online weight loss + Incentives for behavior 12 months
- BEHAVIORAL Online weight loss + Incentives for weight loss 12 months
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-01 |
| Est. Completion | 2016-06 |
| Phase | Phase 3 |
What the finished NCT02008474 record still lists
NCT02008474 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 4 interventions - of which Online weight loss + incentives for behavior 3 months is the first listed.
NCT02008474 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02008474 about?
NCT02008474 is a clinical study titled "SHARE Study 4: Financial Incentives for Weight Loss". The purpose of this study is to examine different types of monetary incentive paradigms for weight loss.
What is the current status of trial NCT02008474?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2014-01. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02008474?
The interventions under investigation include: Online weight loss + incentives for behavior 3 months (BEHAVIORAL), Online weight loss + incentives for weight loss at month 3 (BEHAVIORAL), Online weight loss + Incentives for behavior 12 months (BEHAVIORAL), Online weight loss + Incentives for weight loss 12 months (BEHAVIORAL).
Who is sponsoring clinical trial NCT02008474?
This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02008474's enrollment target sits among peer trials
120 1619th of 2000 higher than 361 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia